Laura Francis - May 16, 2023 Form 4 Insider Report for SI-BONE, Inc. (SIBN)

Signature
/s/ Michael A. Pisetsky, Attorney-in-Fact for Laura A. Francis
Stock symbol
SIBN
Transactions as of
May 16, 2023
Transactions value $
-$223,779
Form type
4
Date filed
5/18/2023, 05:36 PM
Previous filing
Mar 2, 2023
Next filing
Jun 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SIBN Common Stock Sale -$49.3K -1.98K -0.44% $24.85 451K May 16, 2023 Direct F1, F2
transaction SIBN Common Stock Sale -$54.2K -2.18K -0.48% $24.85 449K May 16, 2023 Direct F1, F3
transaction SIBN Common Stock Sale -$38K -1.53K -0.34% $24.85 447K May 16, 2023 Direct F1, F4
transaction SIBN Common Stock Sale -$25.3K -1.02K -0.23% $24.84 446K May 16, 2023 Direct F1, F5
transaction SIBN Common Stock Sale -$15.4K -621 -0.14% $24.73 446K May 16, 2023 Direct F1, F6
transaction SIBN Common Stock Sale -$41.7K -1.68K -0.37% $24.85 446K May 16, 2023 Direct F1, F4, F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $24.34 USD to $24.99 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 This transaction was executed in multiple trades at prices ranging from $24.34 USD to $24.95 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 This transaction was executed in multiple trades at prices ranging from $24.37 USD to $24.99 USD; the price reported above reflects the weighted average sale price.The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 This transaction was executed in multiple trades at prices ranging from $24.34 USD to $24.96 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 This transaction was executed in multiple trades at prices ranging from $24.37 USD to $24.85 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 Includes 1,892 shares acquired under the SI-BONE, Inc. 2018 Employee Stock Purchase Plan on May 15, 2023.
F8 Includes 270,283 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.